JTI debuts new “Ploom X Advanced” in South Korea, full rollout set for November

Oct.28.2024
JTI debuts new “Ploom X Advanced” in South Korea, full rollout set for November
JTI Korea unveils new HTP “Ploom X Advanced,” set for online release on November 4 at a suggested retail price of $50. The company aims to capture a 10% share of the global e-cigarette market within the next 3 to 4 years.

According to a report from N. News on October 28, Japan Tobacco International Korea (JTI) announced at a press conference in Seoul on the same day the launch of the heated tobacco product (HTP) "Ploom X Advanced" in South Korea.

 

JTI debuts new “Ploom X Advanced” in South Korea, full rollout set for November
Japan Tobacco International Korea (JTI) holds a press conference for the launch of "Ploom X Advanced" | Image Source: N. News

 

David Wheeler, CEO of JTI Korea, stated during a press conference that South Korea is the fourth largest heated tobacco market globally, with a market share of 20%. In order to adapt to market changes and expand consumer choices, the company has decided that it is necessary to diversify its product portfolio.

 

JTI debuts new “Ploom X Advanced” in South Korea, full rollout set for November
Translation into English: JTI Korea CEO David Wheeler | Image source: N. News

 

Willer pointed out that although JTI was a latecomer in the South Korean market, the timing was very timely. With its innovative technology in the new product "Ploom X Advanced," the company has the ability to compete in the rapidly growing e-cigarette market.

 

JTI debuts new “Ploom X Advanced” in South Korea, full rollout set for November
Ploom X Advanced" New Product Showcase | Image Source: N. News

 

According to the introduction, the newly launched "Ploom X Advanced" core technology "Heatflow" can increase the heating temperature to 320 degrees. The product can be used unlimited times within 5 minutes of use, and can continuously use up to 3 pods at a time. After charging for 90 minutes, it can support up to 20 pods.

 

The exclusive pod brand for "Ploom X Advanced" is "MEVIUS", offering five choices including Deep Regular, Ice Cold, Purple Option, Baise Option, and Shine Fresh.

 

The new product will be released for the first time on the Ploom website on November 4th, with 100 limited edition pre-sale packages available. The suggested retail price is 69,000 Korean won (approximately $50 USD), with a discount available for first-time buyers. On November 12th, the new product will also be available for sale at convenience stores and e-commerce platforms in the Seoul area.

 

JTI Korea launched "Ploom Tech" in 2019, but due to poor market share and the impact of anti-Japanese activities in Japan, it ceased sales in 2021.

 

According to data from the South Korean Ministry of Finance, the market share of HTP increased from 10.5% in 2019 to 14.8% in 2022, reaching 16.9% in the first half of last year. JTI stated that their goal is to achieve a 10% market share in the global e-cigarette market within the next 3 to 4 years.

 

The CEO, Mr. Wei Le, stated that, "The new product, designed with consumers in mind, offers "modern enjoyment" that matches the lifestyle and choices of modern consumers. It incorporates excellent and innovative technology, as well as perfect design options. We believe it will become the most popular way for South Koreans to enjoy the original flavor of tobacco."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
KT&G has introduced nicotine pouch brand LOOP in South Africa, expanding its modern oral nicotine portfolio. Developed by Swedish company Another Snus Factory (ASF), LOOP is a tobacco-free nicotine pouch brand. KT&G and U.S. tobacco company Altria previously participated in ASF’s strategic development, and the South Africa launch represents a further step in LOOP’s international expansion.
Aug.06
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
Acme Vape Ltd, the company behind UK vaping brand IVG, has received HM Revenue & Customs approval to operate an excise warehouse for vaping products and participate in the Vaping Duty Stamps Scheme. The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Acme Vape Ltd says its approved warehouse in Preston will become operational under the new regime on the same date.
Regulations
Sep.18 by 2Firsts Perspectives